Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
User

Thomas Graham, Alan, Irving Kahns

Kahn Brothers Group

Kahn Brothers Group Hologic Inc stake

total: 111

Kahn Brothers Group HOLX trades

Total transactions:
44
New positions:
1
Sold out:
1
Added:
5
Reduced:
37
Held since:
2013 Q2 or earlier
Held for:
48+ quarters
Latest activity:
2025 Q2
According to 2026 Q1 report, Kahn Brothers Group doesn't hold any Hologic Inc (HOLX) shares. Kahn Brothers Group has held HOLX since at least 2013 Q2 with about 1.54M shares in our earliest available record. Since at least 2013 Q2, Kahn Brothers Group has made 43 more transactions.

When did Kahn Brothers Group sell Hologic Inc (HOLX)?

Kahn Brothers Group sold off the entire Hologic Inc (HOLX) position in 2025 Q2.

Estimated cost basis*

Weighted AVG buy price:
$19.87
Weighted AVG sell price:
$40.25

Kahn Brothers Group's historical trades in Hologic Inc

44 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2025 Q2
0.00%
0
$61.78
-100% (-19,757)
-0.25%
2025 Q1
0.25%
19,757
$61.78
$1,220,644
-33.23% (-9,834)
-0.13%
2024 Q4
0.46%
29,591
$72.10
$2,133,617
+15.63% (+4,000)
+0.06%
2024 Q2
0.32%
25,591
$74.26
$1,900,332
-3.40% (-900)
-0.01%
2024 Q1
0.31%
26,491
$77.95
$2,064,995
-7.02% (-2,000)
-0.02%
2023 Q3
0.31%
28,491
$69.39
$1,977,000
-5.14% (-1,544)
-0.02%
2023 Q1
0.35%
30,035
$80.71
$2,424,000
-1.15% (-350)
-0%
2022 Q4
0.30%
30,385
$74.81
$2,273,000
-5.00% (-1,600)
-0.02%
2022 Q1
0.31%
31,985
$76.82
$2,457,000
-1.70% (-554)
-0.01%
2021 Q4
0.34%
32,539
$76.56
$2,491,186
-8.65% (-3,080)
-0.03%
2021 Q3
0.37%
$73.81
-10.41% (-4,138)
2021 Q2
0.38%
$66.72
-10.52% (-4,672)
2021 Q1
0.51%
$74.38
-2.88% (-1,317)
2020 Q4
0.58%
$72.83
+7.77% (+3,300)
2020 Q3
0.53%
$66.47
-48.56% (-40,073)
2020 Q2
0.79%
$57.00
-69.04% (-183,986)
2020 Q1
1.71%
$35.10
-9.53% (-28,066)
2019 Q4
1.86%
$52.21
-4.93% (-15,266)
2019 Q3
1.96%
$50.49
-8.79% (-29,865)
2019 Q2
2.04%
$48.02
-0.22% (-742)
2019 Q1
2.57%
$48.40
-38.12% (-209,704)
2018 Q4
4.08%
$41.10
-4.83% (-27,937)
2018 Q3
3.64%
$40.98
-5.39% (-32,942)
2018 Q2
3.86%
$39.75
-7.14% (-46,970)
2018 Q1
3.92%
$37.36
-4.87% (-33,670)
2017 Q4
4.64%
$42.75
-5.49% (-40,149)
2017 Q3
4.10%
$36.69
-8.46% (-67,649)
2017 Q2
5.53%
$45.38
-12.95% (-118,934)
2017 Q1
6.72%
$42.55
-23.30% (-279,005)
2016 Q4
8.11%
$40.12
-3.01% (-37,110)
2016 Q3
8.68%
$38.83
-3.33% (-42,470)
2016 Q2
8.55%
$34.57
-3.73% (-49,500)
2016 Q1
8.57%
$34.50
-1.76% (-23,767)
2015 Q4
9.33%
$38.69
+0.61% (+8,239)
2015 Q3
9.72%
$39.13
-1.31% (-17,800)
2015 Q2
8.73%
$38.06
-1.31% (-17,990)
2015 Q1
7.69%
$33.02
-3.00% (-42,640)
2014 Q4
2.04%
$8.32
-7.83% (-120,717)
2014 Q3
6.10%
$24.33
-0.04% (-570)
2014 Q2
5.69%
$25.35
-0.98% (-15,250)
2014 Q1
4.78%
$21.50
+15.37% (+207,409)
2013 Q4
5.19%
$22.35
-12.92% (-200,200)
2013 Q3
4.66%
$20.65
+0.51% (+7,900)
2013 Q2
4.59%
$19.30
new or own*
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.